Related Experiment Video
Updated: Oct 5, 2025
13:35
Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
3.1K
Current Progress in Breast Implant-Associated Anaplastic Large Cell Lymphoma
Yichen Wang1, Qi Zhang1, Yufang Tan1
1Department of Plastic and Cosmetic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Frontiers in Oncology
|January 24, 2022
Summary
Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a rare T-cell lymphoma linked to breast implants. Textured implants are strongly associated, highlighting the need for safer material choices in breast surgeries.
Area of Science:
- Oncology
- Immunology
- Biomaterials Science
Background:
- Breast implant-associated anaplastic large-cell lymphoma (BIA-ALCL) is a rare T-cell malignancy.
- Epidemiological data indicate a link between BIA-ALCL and breast augmentation/reconstruction procedures.
- Concerns regarding the biosafety of breast implants have been raised due to BIA-ALCL incidence.
Purpose of the Study:
- To review the etiology, pathogenesis, diagnosis, and therapy of BIA-ALCL.
- To examine the physical characteristics of breast implants and their pathogenic effects.
- To provide a basis for selecting breast implants with reduced morbidity.
Main Methods:
- Literature review focusing on BIA-ALCL and breast implant characteristics.
- Analysis of epidemiological data and case reports.
- Synthesis of current evidence on risk factors and pathogenesis.
Main Results:
- Textured breast implants are implicated in nearly all reported BIA-ALCL cases.
- Genetic factors, bacterial contamination, and chronic inflammation are contributing factors.
- Implant surface characteristics play a crucial role in BIA-ALCL development.
Conclusions:
- Understanding implant surface properties is key to BIA-ALCL prevention.
- Further research into biomaterial safety is warranted for breast reconstruction and augmentation.
- Informed choices regarding implant type can minimize patient risk and morbidity.
